StockData
Enliven Therapeutics, Inc. logo

Enliven Therapeutics, Inc. (ELVN) stock

ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$44.89−1.96 (-4.18%)

Close on Nov 18, 2026Market cap $3.29BP/E –Yield –

Enliven Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Enliven Therapeutics's market cap was $3.75B on Nov 11, 2026, against $1.28B a year earlier. Over the last 5 years it ranged from $14.76M to $4.24B, with a median of $912.62M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.75B+310.9%
2025Dec 31, 2025$912.62M-14.2%
2024Dec 31, 2024$1.06B+86.4%
2023Dec 29, 2023$570.28M+1005.0%
2022Dec 30, 2022$51.61M+81.9%
2021Dec 31, 2021$28.38M-84.6%
2020Dec 31, 2020$183.92M–

More Enliven Therapeutics figures

See a number that looks wrong?